Skip to main content

The Inflation Reduction Act caps costs for Medicare patients on insulin. Where the push for broader relief stands

The Inflation Reduction Act will limit insulin co-pays for Medicare patients to $35 per month. Where efforts to provide similar relief to other patients stand.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.